ArticleBritish journal of cancer2017

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.

Rachna T Shroff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.